Representative before the EPO

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1157.45
Headquarter in London and 9 offices
active in Legal Services and IP Consulting

Representative before the EPO

Employment test 11 - 50 employees
Company dna wallinger ricker schlotter tostmann
operating since 1989
Headquarter in Munich
active in Legal Services

We have observed 3 EP applications Uli Foerstl has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after August 15, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12004148

Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein

IPC classification:
C12N 15/86
Agent:
Uli Foerstl, Olswang
Agent:
Uli Foerstl, D Young & Co LLP
Agent:
Multiple attorneys, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS
EP13002972

Semi-live respiratory syncytial virus vaccine

IPC classification:
A61K 39/155, C12N 15/86, C12N 7/00, C12N 5/10
Agent:
Uli Foerstl, Olswang
Agent:
Multiple attorneys, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
GRANT OF PATENT INTENDED
EP13727047

METHOD FOR EXPRESSION OF HETEROLOGOUS PROTEINS USING A RECOMBINANT NEGATIVE-STRAND RNA VIRUS VECTOR

IPC classification:
C12N 15/86, C12N 5/071
Agent:
Uli Foerstl, Olswang
Agent:
Uli Foerstl, D Young & Co LLP
Agent:
Multiple attorneys, Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature